Healthcare & Medical Devices Global On demand · 24-48h

Global Graft Delivery Device Market Strategic Research Report

Global Graft Delivery Device Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Graft Delivery Device Market
$1.92B2025
8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Bone Graft Delivery Device, Fat gGraft Delivery Device, Vascular Graft Delivery Device, Others

By Application: Hospitals, Ambulatory surgery centers (ASCs), Specialty clinics

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Arthrex, Inc., Stryker, Medtronic, SurGenTec, Pinnacle Spine Group, W. L. Gore & Associates, Cook Medical, Terumo Corporation, Cordis, Abbott Laboratories, Endovastec, Lifetech Scientific Corporation, Beijing Aortec Medical Technology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$1.92B
Billion USD
Forecast CAGR
8%
2025-2032
Forecast 2032
$3.3B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Graft Delivery Device market size is predicted to grow from US$ 1,924 million in 2025 to US$ 3,301 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.

A Graft Delivery Device is a minimally invasive catheter-based medical device system designed to deliver, position, and deploy a stent graft inside diseased blood vessels, most commonly for Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR) procedures. In 2025, global Graft Delivery Device production reached approximately 419.26 K Units. The upstream of the SGDS industry includes polymer materials (PTFE, PET), Nitinol and cobalt-chromium alloys, stainless steel, and radiopaque materials.

The Graft Delivery Device is a critical component of endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) procedures. It enables minimally invasive delivery, precise positioning, and controlled deployment of stent grafts within diseased vessels, particularly for treating abdominal and thoracic aortic aneurysms and dissections. The Graft Delivery Device market is closely integrated with the broader structural heart and endovascular intervention ecosystem, including stent grafts, catheter delivery systems, and imaging-guided navigation technologies. Market growth is primarily driven by the rising prevalence of aortic aneurysms and dissections, an aging global population, and the ongoing shift from open surgery to minimally invasive endovascular procedures. EVAR and TEVAR have become standard-of-care treatments in developed markets and are rapidly expanding into emerging regions such as China, Southeast Asia, and Latin America. In addition, advancements in imaging guidance and patient-specific stent graft customization are further increasing procedural success rates and expanding indications, thereby supporting continued growth and technological upgrading of delivery systems.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Graft Delivery Device market?

What factors are driving Graft Delivery Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Graft Delivery Device market opportunities vary by end market size?

How does Graft Delivery Device break out by Type, by Application?

This report presents a comprehensive overview of the global Graft Delivery Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Bone Graft Delivery Device
  • Fat gGraft Delivery Device
  • Vascular Graft Delivery Device
  • Others

Segment by Deployment Mechanism

  • Self-expanding Systems
  • Balloon-expandable Systems
  • Hybrid Release Systems

Segment by Material & Design

  • Single-lumen Delivery System
  • Multi-lumen Precision System
  • Low-profile Systems

Segment by Procedural Complexity

  • Standard Anatomy Cases
  • Fenestrated/Branched Anatomy
  • Complex Aortic Reconstruction

Segment by Application

  • Hospitals
  • Ambulatory surgery centers (ASCs)
  • Specialty clinics

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Graft Delivery Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Ambulatory surgery centers (ASCs), Specialty clinics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Graft Delivery Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.92B
2025
Forecast
$3.3B
2032
CAGR
8%
2025–2032
Regions
5
global
Key companies
Arthrex, Inc.StrykerMedtronicSurGenTecPinnacle Spine GroupW. L. Gore & AssociatesCook MedicalTerumo Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Bone Graft Delivery DeviceFat gGraft Delivery DeviceVascular Graft Delivery DeviceOthers
By Application
HospitalsAmbulatory surgery centers (ASCs)Specialty clinics

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Bone Graft Delivery Device
  • 3.1.3 Fat gGraft Delivery Device
  • 3.1.4 Vascular Graft Delivery Device
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Ambulatory surgery centers (ASCs)
  • 4.1.4 Specialty clinics
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Arthrex, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Stryker
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 SurGenTec
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Pinnacle Spine Group
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 W. L. Gore & Associates
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cook Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Terumo Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Cordis
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Abbott Laboratories
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Endovastec
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Lifetech Scientific Corporation
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Beijing Aortec Medical Technology Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Graft Delivery Device market size?
The global Graft Delivery Device market is estimated at US$ 1.92 billion in 2025 (base year) and is projected to reach US$ 3.3 billion by 2032.
What growth rate is expected for the Graft Delivery Device market through 2032?
The market is expected to grow at a CAGR of 8.0% from 2026 to 2032, expanding from US$ 1.92 billion in 2025 to US$ 3.3 billion in 2032, roughly 1.7 times its base-year value.
How is Graft Delivery Device defined?
A Graft Delivery Device is a minimally invasive catheter-based medical device system designed to deliver, position, and deploy a stent graft inside diseased blood vessels, most commonly for Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR) procedures. In 2025, global Graft Delivery Device production reached approximately 419.26 K Units. The upstream of the SGDS industry includes polymer materials (PTFE, PET), Nitinol and cobalt-chromium alloys, stainless steel, and radiopaque materials.
What are the main segments of the Graft Delivery Device market by type?
By type, the market is segmented into Bone Graft Delivery Device, Fat gGraft Delivery Device, Vascular Graft Delivery Device and Others.
Which applications drive demand in the Graft Delivery Device market?
Key applications covered include Hospitals, Ambulatory surgery centers (ASCs) and Specialty clinics.
Who are the key players in the Graft Delivery Device market?
Key players profiled include Arthrex, Stryker, Medtronic, SurGenTec, Pinnacle Spine Group, W. L. Gore & Associates, Cook Medical and Terumo Corporation, among 13 companies covered in total.
Which regions and countries are covered for Graft Delivery Device?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Graft Delivery Device market?
Market growth is primarily driven by the rising prevalence of aortic aneurysms and dissections, an aging global population, and the ongoing shift from open surgery to minimally invasive endovascular procedures.
Who should buy the Graft Delivery Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Ambulatory surgery centers (ASCs) and Specialty clinics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Graft Delivery Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.